Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2018 May 9;24(8):1651–1656. doi: 10.1016/j.bbmt.2018.04.025

Table 2.

Treosulfan PK profile by BSA-based dosing groups

Treosulfan dose (g/m2)
10 12 14
N 5 10 4
PK Parameter
Age (years) *,+,#, 1 (0.9–1) 6 (4–8) 9 (9–11)
BSA (m2) *,+,#, 0.43 (0.38–0.50) 0.86 (0.52–0.99) 1.11 (1.05–1.40)
Weight (kg) *,+,#, 9.2 (8.1–14.6) 22.7 (19.4–25.1) 30.7 (30.1–37.5)
AUC (mcg/mL*h) 2762 ± 1058 2240 ± 538 2235 ± 96
Cmax (mcg/mL) 977 ± 412 799 ± 201 788 ± 28
t½ (h) 1.39 ± 0.25 1.49 ± 0.14 1.38 ± 0.11
Vss (L) *,+, 6.7± 2.3 9.5 ± 2.5 9.9 ± 0.6
CL (mL/min) *,+, 69.4 ± 22.5 94.9 ± 18.2 104.5 ± 4.5

AUC: area under the curve; Cmax: maximum concentration; t½: half-life; Vss: volume of distribution; CL: total clearance

AUC, Cmax, t½Vss and CL expressed in mean + standard deviation (SD)

Age, BSA and weight expressed in median (range)

*,+,#Significant differences between BSA-based treosulfan doses (p < 0.05 (using t-test)):

*

10 vs.12 g/m2;

+

10 vs.14 g/m2;

#

12 vs.14g/m2